Elimination Of Tax Deferral On Foreign Income Still A "Valid Concern," J&J Says
This article was originally published in The Pink Sheet Daily
Efforts to eliminate a tax deferral on income generated by multinationals overseas and healthcare reform would be a one-two punch to Big Pharma.
You may also be interested in...
Republican Senator has long said she will oppose bill with a public insurance plan.
Abbott Laboratories announced plans to acquire Solvay's pharmaceutical business for $6.6 billion Sept. 28, a strategic maneuver that seems as much about adding revenues to Abbott's top-line as addressing long-term challenges in the pharmaceutical pipeline
Is it over? Elan Corp. and Johnson & Johnson said Sept. 17 they successfully closed their deal to share Alzheimer disease programs